Shuangqin Fan
Guiyang Medical University(CN)Affiliated Hospital of Guizhou Medical University(CN)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Nanoplatforms for cancer theranostics, Metabolism, Diabetes, and Cancer, Pancreatic and Hepatic Oncology Research, Cancer-related Molecular Pathways
Most-Cited Works
- → Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α(2021)72 cited
- → <p>Oxymatrine reverses epithelial-mesenchymal transition in breast cancer cells by depressing α<sub>Ⅴ</sub>β<sub>3</sub> integrin/FAK/PI3K/Akt signaling activation</p>(2019)32 cited
- → Shikonin blocks CAF-induced TNBC metastasis by suppressing mitochondrial biogenesis through GSK-3β/NEDD4-1 mediated phosphorylation-dependent degradation of PGC-1α(2024)24 cited
- → Inhibition of Mitochondrial Biosynthesis Using a “Right‐Side‐Out” Membrane‐Camouflaged Micelle to Facilitate the Therapeutic Effects of Shikonin on Triple‐Negative Breast Cancer(2022)21 cited
- → Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect(2023)19 cited
- → GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells(2022)14 cited
- → Inhibition of Mitochondrial Biosynthesis Using a “Right‐Side‐Out” Membrane‐Camouflaged Micelle to Facilitate the Therapeutic Effects of Shikonin on Triple‐Negative Breast Cancer (Adv. Healthcare Mater. 18/2022)(2022)